MarginsXMarginsX
Home › Markets › Health Care › YARW

Yarrow Bioscience Inc. (YARW)

YARW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$13.93
-22.74% on the day
Market cap
$212.2M
Micro cap
Revenue · 2025
$570K
+13.8% on 2024
Net income · 2025
-$26.5M
-4646.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/0001566044-26-000002-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerYARW on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2018
SEC CIK0001566044
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$570K
Net income-$26.5M
Operating income-$29.7M
Net margin-4646.1%
Operating margin-5219.1%
Revenue growth+13.8%
Cash$24.0M
Total assets$30.2M
P/E (computed)Net income was not positive
P/S (computed)372.3×

Warning signs

Cash runway
9.7 months
$22.9M cash at June 30, 2026
Share count, 1 year
See the dilution note
+5357.7% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$22.9M cash; operating cash flow -$7.1M a quarter.Report 2026-06-30
Shares outstanding15,234,944 (2026-11-03); 13,957,324 three years earlier. 3y figure adjusted for splits (1-for-50 overall).Cover page 2026-11-03
Reverse splits, 3 years1; latest 1-for-50 on 2026-07-27Source 2026-07-27
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-09-11
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-03-11
AuditorBaker Tilly US, LLP, Tewksbury, Massachusetts, United StatesPCAOB Form AP 2026-03-31
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 9,304,361 shares at the 2026-11-13 price; the latest SEC cover count is 15,234,944 as of 2026-11-03. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$97K-$3.0M-$2.0M$22.9M$0Needs four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
$86K-$3.6M-$4.1M$24.6M$0Needs four quarters10-Q 2026-05-15
Q2 2025
2025-06-30
$69K-$5.8M-$10.8M$22.0M$0$476K10-Q 2026-08-13
Q1 2025
2025-03-31
$202K-$8.6M-$11.5M$28.2M$0$605K10-Q 2026-05-15
Q4 2024
2024-12-31
$84K-$12.0M-$9.0M$19.9M$0$501K10-K 2026-02-27
Q3 2024
2024-09-30
$121K-$12.2M-$8.5M$16.3M$0$493K10-Q 2024-11-07
Q2 2024
2024-06-30
$198K-$9.4M-$8.5M$29.6M$0$486K10-Q 2025-08-14
Q1 2024
2024-03-31
$98K-$6.2M-$8.0M$19.1M$0$423K10-Q 2025-05-08

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-11
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-12
Latest proxyDEF 14A2025-11-12

Source: SEC EDGAR submissions feed, 692 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+15.6%
1 month-3.1%
3 months-57.8%
Year to date-37.8%
1 year-2.3%
From 52-week high-60.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ACIUAC Immune SA$2.09-1.88%$212.7M
VOGXVogenx Inc$14.38-13.74%$213.6M
CYPHCypherpunk Technologies Inc.$1.93+2.94%$207.4M
SIGASIGA Technologies Inc.$2.85+4.01%$204.8M
DRUGBright Minds Biosciences Inc.$22.61-2.16%$222.0M
BCYCBicycle Therapeutics plc$3.18-5.64%$222.9M
GLSIGreenwich LifeSciences Inc.$13.76-7.90%$202.0M
IMRXImmuneering Corporation$3.52-5.12%$228.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier